Government panel outlines needed global, U.S. action
Government panel outlines needed global, U.S. action
Far-reaching plans watch globally, act locally
The interagency government working group on emerging infectious diseases -- formed under the auspices of the National Science and Technology Council's Committee on International Science, Engineering, and Technology -- made the following recommendations for the U.S. government to meet the threat1:
Global: Work in partnership with other countries, the World Health Organization (WHO) in Geneva, and other international organizations to improve worldwide disease surveillance, reporting, and response by:
* Establishing regional disease surveillance and response networks linking national health ministries, WHO regional offices, U.S. government laboratories and field stations abroad, foreign laboratories and medical centers, and WHO collaborating centers.
* Ensuring that reliable lines of communication exist between local and national medical centers, and between national and regional or international reference facilities, especially in parts of the world lacking modern communications.
* Developing a global alert system whereby national governments can inform appropriate worldwide health authorities of outbreaks of infectious diseases in a timely manner, and whereby individual health authorities can access regional centers.
* Identifying regional and international resources that can provide diagnostic reagents for low-incidence diseases and help identify rare and unusual diseases.
* Assisting WHO to establish global surveillance of antibiotic resistance and drug use as a first step toward developing international agreements on antibiotic usage.
* Encouraging and assisting other countries to make infectious disease detection and control a national priority.
* Preserving existing U.S. government activities that enhance other countries' abilities to prevent and control emerging and re-emerging health threats.
* Identifying and strengthening WHO collaborating centers that serve as unique reference centers for diseases whose re-emergence is feared.
* Establishing the authority of relevant U.S. government agencies to make the most effective use of their expertise in building a worldwide disease surveillance and response network.
More collaboration needed
Domestic: Strengthen the United States' capacity to combat emerging infectious diseases by:
* Enhancing collaborations among U.S. agencies to ensure maximum use of existing resources for domestic and international surveillance and response activities.
* Rebuilding the U.S. infectious disease surveillance public health infrastructure at the local, state, and federal levels.
* Working with the private and public sectors to improve United States' capacity for the emergency production of diagnostic tests, drugs, and vaccines.
* Supporting an active community of epidemiologists, clinical investigators, laboratory scientists, health experts, and behavioral scientists ready and able to seek new solutions for new disease threats.
* Strengthening technical training programs in disciplines related to infectious disease surveillance and response.
* Providing accurate and timely health information to private citizens and health providers, both in the United States and abroad, when a disease outbreak occurs.
* Strengthening infectious disease screening and quarantine efforts at ports of entry.
* Strengthening the training of American physicians and microbiologists in the recognition of tropical diseases and in travel medicine in general.
* Establishing an interagency task force to coordinate the implementation of these recommendations. Establish a private sector subcommittee of the task force that includes representatives of the pharmaceutical industry, medical practitioners and educators, and biomedical scientists.
Reference
1. National Science and Technology Council. Committee on International Science, Engineering, and Technology. Working group on emerging and re-emerging infectious diseases. Infectious Disease -- A Global Health Threat. Washington, DC; 1995. *
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.